As reminded by a Caixin article on Tuesday evening, overnight and into the morning, overseas markets have been busy reassessing the prospects of the Middle East conflict, with the three major US stock indices collectively under pressure and declining.
As of Tuesday’s close, the S&P 500 fell 0.84% to 5,982.72 points; the Nasdaq Composite Index fell 0.91% to 19,521.09 points; and the Dow Jones Industrial Average fell 0.7% to 42,215.8 points. As a bellwether for the Middle East conflict, international oil prices surged again.
(Daily chart of Brent crude oil, source: TradingView)
According to CCTV News, as the military conflict between Israel and Iran continues, the market’s focus has shifted to whether the US military will intervene. According to reports, US President Trump met with his national security team in the White House Situation Room on Tuesday to weigh whether to further intervene in the ongoing conflict between Israel and Iran.
US Treasury bond prices also rose simultaneously, though this was also related to weak US retail, housing, and industrial output data. Later on Wednesday (early Thursday Beijing time), the US Fed will announce its latest interest rate decision and hold a press conference. The market generally expects that before a series of uncertainties that could trigger inflation are resolved, Fed officials will have no room to cut interest rates.
Meanwhile, Andrew Tyler, head of global market intelligence at JPMorgan Chase, who successfully predicted the April rebound, said this week that despite the success of investors’ strategy of buying the dip in the US stock market this year, with negative news always being rewarded after fading away, it is now best to reduce risk exposure. Regardless of the Israel-Iran situation, the US stock market itself is already ripe for a correction.
The latest Bank of America Fund Manager Survey also shows that about 54% of institutional investors expect international stocks to be the best-performing asset class over the next five years, while only 23% choose US stocks.
Performance of Popular Stocks
Tech giants generally fell on Tuesday, with Apple down 1.4%, Microsoft down 0.23%, Amazon down 0.59%, Nvidia down 0.39%, Google-A down 0.46%, Tesla down 3.88%, and Meta down 0.7%.
Chinese ADRs also weakened due to market sentiment, with the Nasdaq Golden Dragon China Index closing down 1.77%.
As of the close, Alibaba was down 0.8%, JD.com was down 0.93%, Baidu was down 1.42%, Pinduoduo was down 0.25%, Bilibili was down 2.6%, NIO was down 2.27%, NetEase was down 1.12%, and Futu Holdings was down 1.47%.
The “Traditional Chinese Medicine + Brain-Computer Interface” concept stock that captured market attention yesterday,Brain Regeneration Technology,continued to rise by 30%, reaching a market capitalization of $38.5 billion, with a cumulative increase of 59,900% since the beginning of the year. It should be emphasized that the core reason for the stock’s speculative surge lies in its extremely small free float.
Company News
[Amazon CEO Issues Warning on “AI Taking Jobs”]
On Tuesday local time, Andy Jassy, CEO of Amazon, the world’s largest e-commerce and cloud computing platform, publicly wrote that as the company widely adopts AI to enhance efficiency, it is expected that the overall workforce will be reduced.
[US Energy Giant Chevron Officially Enters Lithium Industry]
US energy giant Chevron announced on Tuesday its entry into the lithium industry. The company acquired two oilfield areas with the intention of building a “commercial-scale” lithium business in the US. Chevron stated that in the future, it will utilize the “Direct Lithium Extraction” (DLE) process at oilfields to extract lithium from brine.
[Coinbase to Seek SEC Approval for Tokenized Equities]
Paul Grewal, Chief Legal Officer of Coinbase, a cryptocurrency exchange and newly added member of the S&P 500 Index, revealed that the company is seeking approval from the US Securities and Exchange Commission (SEC) to launch a “tokenized equities” service.
[Eli Lilly to Acquire Gene-Editing Startup Verve for $1.3 Billion]
On Tuesday Eastern Time, US pharmaceutical giant Eli Lilly announced that it would acquire gene-editing startup Verve Therapeutics for up to $1.3 billion. In response to this news, Verve’s stock price closed up 81.50% on Tuesday.
[JPMorgan Chase Launches Deposit Token JPMD, Emphasizing It’s Different from Stablecoins]
JPMorgan Chase stated on Tuesday that it plans to launch a so-called deposit token, JPMD, on Coinbase’s public blockchain Base, which is built on the Ethereum network. The token will provide customers with 24/7 settlement services and the ability to pay interest to holders. The Wall Street giant stated that this is a so-called “permissioned token,” meaning it is limited to JPMorgan Chase’s institutional clients only—different from most publicly circulating stablecoins.
[Tesla’s Stock Falls Due to Temporary Production Halt News]
Tesla’s stock price fell by 3.88% on Tuesday amid news that the company would suspend production of the Cybertruck and Model Y car models at its Austin, Texas, factory for a week. It is reported that the production halt for maintenance will begin on June 30, marking the third similar shutdown at the Austin factory in the past year.
[Meta to Launch AI Glasses in Collaboration with Prada and Oakley]
Market news on Tuesday reported that Meta and its AI glasses partner EssilorLuxottica plan to launch new AI glasses products under the Prada and Oakley brands. Meta had already announced on Monday that it would unveil a new collaboration with Oakley this week, focusing on sports scenarios.
[Intel Reportedly to Cut Up to 20% of Employees in Its Foundry Division]
An internal memo disclosed by the media on Tuesday revealed that Intel plans to reduce its workforce in the foundry business unit by 15% to 20% starting from July. It remains unclear how many employees will be directly affected by this move. Regulatory filings indicate that as of the end of last year, Intel had a total of 108,900 employees.
